docetaxel anhydrous has been researched along with Neoplasms, Otorhinolaryngologic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comans, EF; Lammertsma, AA; Smit, EF; van der Veldt, AA | 1 |
| Balermpas, P; Bauer, C; Fokas, E; Fraunholz, I; Ottinger, A; Rödel, C; Seitz, O; Stöver, T; Wagenblast, J; Weiss, C | 1 |
| Fodor, J; Gödény, M; Hitre, E; Kásler, M; Major, T; Oberna, F; Polgár, C; Remenár, É; Takácsi-Nagy, Z | 1 |
| Ensley, JF; Kim, H; Kucuk, O; Lin, HS; Lonardo, F; Piechocki, MP; Stevens, T; Subramanian, G; Tulunay, OE; Won, J; Yoo, GH | 1 |
| Aikoh, K; Horiuchi, C; Ikeda, Y; Katori, H; Mikami, Y; Ono, M; Sakuma, Y; Taguchi, T; Tanigaki, Y; Tsukuda, M; Yoshida, T | 1 |
2 trial(s) available for docetaxel anhydrous and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Taxoids | 2015 |
Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Humans; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Taxoids | 2004 |
3 other study(ies) available for docetaxel anhydrous and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Effects of chemotherapy on the parotid and submandibular glands in head and neck cancer patients treated with chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Docetaxel; Humans; Induction Chemotherapy; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Parotid Gland; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Submandibular Gland; Taxoids; Xerostomia | 2014 |
Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Retrospective Studies; Taxoids | 2014 |
Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
Topics: Animals; Antineoplastic Agents; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Injections, Intralesional; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Transplantation; Otorhinolaryngologic Neoplasms; Pilot Projects; Salivary Gland Neoplasms; Taxoids; Tumor Burden; Wound Healing | 2008 |